Swissray nears sale of x-ray assets

Article

The first company to introduce a digital radiography system in the U.S. may soon be sold. Swissray International announced Sept. 24 the signing of a nonbinding letter of intent with a U.S.-based private equity firm to acquire all the outstanding shares

The first company to introduce a digital radiography system in the U.S. may soon be sold. Swissray International announced Sept. 24 the signing of a nonbinding letter of intent with a U.S.-based private equity firm to acquire all the outstanding shares of Swissray's capital stock. Swissray has installed its CCD-based ddR (direct digital radiography) systems in the U.S., Europe, the Middle East, and Asia. The company began shopping for a buyer in February at the behest of its major shareholder Hillcrest Avenue, which owns more than 52 million of the company's 91 million common shares. The letter provides for a limited exclusivity period in which to conduct due diligence, to agree on the form and terms of the transaction, and to enter into a definitive contract. Neither Swissray nor its major stockholders may pursue other potential buyers during this time. If the letter of intent is terminated, sale to another buyer within six months will require Swissray to pay a penalty.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.